article thumbnail

The imperative of fridge-free vaccines

European Pharmaceutical Review

Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.

article thumbnail

5 Trends That Will Shape Pharma Marketing in 2021

Pharma Marketing Network

Pharma marketers have quickly learned how to adapt to these trends and are prepared to take on new opportunities in 2021. Trend #1: Media and Tech: Facilitating Communication. Tools that help people track their health, including apps, wearables, and patient portals will be used more than ever in 2021.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Digital innovation drives vaccine development

pharmaphorum

It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation.

article thumbnail

The 2023-2024 Flu Season: What Pharmacists Need to Know

Digital Pharmacist

The most effective preventive measure against the flu is getting an annual flu vaccine. Getting Vaccinated for the Flu The CDC says ideally, everyone who is eligible for a flu vaccine should be vaccinated by the end of October – the ideal time to get vaccinated being September or October.

article thumbnail

Germany backtracks on AZ COVID vaccine age restriction

pharmaphorum

Germany has decided that AstraZeneca’s COVID-19 vaccine should be approved for use in the over-65s after all, reversing its earlier restriction in that age group. . — Jens Spahn (@jensspahn) March 4, 2021. France has said the vaccine can be used in people aged up to 74, rather than the entire over 65s age group.

article thumbnail

Moderna takes aim at global expansion plans with manufacturing ramp-up

Pharmaceutical Technology

In 2020, Moderna made a net loss of $747 million while its investigational mRNA vaccines were under development. However, during the Covid-19 pandemic, the US-based biotech rose to prominence as it was one of the first companies to develop Covid-19 vaccines with its mRNA technology. In 2021, Moderna had a net income of $12.2

article thumbnail

Healthier Together and philanthropic ventures in tropical disease

European Pharmaceutical Review

This is in line with the targets set by both the United Nation (UN)’s Sustainable Development Goal 3 on NTDs and the World Health Organization (WHO)’s Neglected Tropical Disease Roadmap (2021-2030). reducing AMR by advancing the vaccine pipeline, including first-in-class vaccines against invasive non-typhoidal salmonellosis and shigellosis .